#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News INFOGRAPHIC: How does liposomal ozonized oil work in treating eye infections?

Ozonized sunflower oil exhibits antimicrobial, anti-inflammatory, and healing properties, which is why it is added to eye drops intended for infection prevention. We bring you a clear schematic of the mechanism of action of liposomal ozonized oil.
Source: Treatment of Glaucoma 24. 3. 2023

News Inosine pranobex in the treatment of influenza and other respiratory infections of viral etiology

The antiviral inosine pranobex is a clinically proven immunomodulator for the treatment of patients from 1 year of age, indicated for a wide range of diseases with manifestations of immune insufficiency and viral infections. It acts by a direct antiviral effect, modulates the immune system, and also finds application in the treatment of acute viral respiratory diseases, such as influenza and other seasonal viral infections.
Source: Viral infections 24. 2. 2022

News Liposomal Ozonated Oil in the Treatment of Eye Infections

Liposomal ozonated oil is a new ocular antiseptic with antibacterial, anti-inflammatory, and regenerative properties, making it suitable for the prevention and treatment of eye infections and as an adjuvant in wound healing. In June 2022, Spanish authors published a review summarizing findings on the mechanism of action and results of preclinical and clinical studies with ozonated oil in the treatment of eye infections and in the regeneration of the ocular surface. It also highlights the benefits of ozonated oil compared to conventional antiseptics such as povidone-iodine and chlorhexidine.
Source: Treatment of Glaucoma 24. 3. 2023

News Successful Resection of a Rectosigmoid Tumor After Long-term Induction Biochemotherapy – A Case Report

Neoadjuvant treatment (chemoradiotherapy) for colorectal cancer is regularly used in advanced rectal tumors, with the goal of reducing the tumor size for the surgeon and ensuring the best possible radical outcome for the patient. In metastatic tumors of the remaining parts of the digestive tract, we talk more about induction treatment, which uses a combination of targeted therapy and chemotherapy for the same purpose – reducing the extent of the tumor disease and possibly enabling surgery including radical removal of metastatic foci. The duration of this treatment is usually up to 6 months followed by surgery (surgeries). The following case report describes a successful surgical solution in a patient with an advanced sigmoid tumor even after more than 3 years of combination chemotherapy and targeted therapy.
Source: Colorectal Cancer 20. 6. 2022

News Impact of Azacitidine Maintenance Therapy on Survival of Patients with AML in Remission Depending on Initial Chemotherapy

The QUAZAR AML-001 study showed that oral azacitidine maintenance therapy significantly prolongs relapse-free survival (RFS) and overall survival (OS) in patients with acute myeloid leukemia (AML) in first remission after intensive chemotherapy (including induction ± consolidation therapy), who are not candidates for hematopoietic stem cell transplantation (HSCT), compared to placebo. In October 2023, results of a subgroup analysis of patients stratified according to the use/non-use of consolidation chemotherapy and the number of consolidation chemotherapy cycles administered before entering the study were published.
Source: Acute Myeloid Leukemia 24. 1. 2024

News Inosine Pranobex in the Treatment of Cervical HPV Infections

The aim of the review article published in the journal Infection and Drug Resistance was to evaluate the available data on the potential use of inosine pranobex in the treatment of patients with a positive human papillomavirus finding in a cervical smear.
Source: Viral infections 13. 7. 2022

Journal articles Palliative care in nephrology

Author of the article: Barbora Szonowská Source: Časopis lékařů českých | 1/2018 19. 3. 2018

News The Role of the General Practitioner in the Care of Incontinent Patients

General practitioners are sometimes likened to frontline soldiers because they are usually the first to whom patients turn with their health issues. Taking care of incontinent patients is a daily routine for them. They should therefore be knowledgeable about basic diagnostics and treatment and be able to actively identify incontinent patients.
Source: Incontinence 2. 6. 2020

News Current (and Future) Possibilities for Diagnosing Alpha-1-Antitrypsin Deficiency

Alpha-1-antitrypsin deficiency (AAT) is associated, among other things, with the development of chronic obstructive pulmonary disease (COPD) with emphysema. Most patients, however, remain undiagnosed and therefore do not receive adequate treatment. Below we summarize the current possibilities for diagnosing this genetic disorder.
Source: Deficiency of Alpha-1-Antitrypsin 25. 2. 2022

News Treatment of COPD in Individuals with Alpha-1 Antitrypsin Deficiency

A mutation in the gene for alpha-1 antitrypsin (AAT), leading to its deficiency (AATD), causes progressive irreversible destruction of lung tissue. Patients develop chronic obstructive pulmonary disease (COPD) and early emphysema. Several studies evaluating COPD treatment have excluded patients with AATD. The aim of the following systematic literature review was to find and analyze works that include patients with concurrent COPD and AATD and summarize key findings that may form the basis for treatment decisions.
Source: Deficiency of Alpha-1-Antitrypsin 6. 12. 2021

News Alopecia Areata – Autoimmune Inflammatory Disease and a New Targeted Treatment Option

Alopecia areata (AA) is one of the non-scarring focal alopecias. It is an autoimmune disease of the hair follicle, the etiopathogenesis of which is not entirely understood. At the hair root, a lymphocytic inflammatory infiltrate develops, resulting in follicle miniaturization and the growth of a thin dystrophic hair. Recently, however, a new strategy for the treatment of AA has emerged, focusing on reducing inflammation of the hair follicle by inhibiting Janus kinases (JAK). This is the first therapeutic modality officially approved for this indication.
Source: Biological Treatment 31. 10. 2022

News Biological treatment of psoriatic arthritis in the 1st line – results of the SPIRIT-H2H study after 1 year of follow-up

The SPIRIT-H2H study compared the efficacy of ixekizumab and adalimumab, either as monotherapy or with concomitant methotrexate (MTX), in patients with psoriatic arthritis (PsA) who had not been previously treated with biologics. The results of the recent work presented below after one year of follow-up suggest that the efficacy of ixekizumab remains the same regardless of the use of MTX, while the efficacy of adalimumab increases in combination with MTX.
Source: Biological Treatment 3. 5. 2021

News Intestinal Infection of Multi-Resistant NDM-Producing K. pneumoniae in a Patient with NK/T Lymphoma – Case Study

The incidence of NDM-producing Klebsiella pneumoniae is increasing worldwide. NDM beta-lactamase is a significant cause of multidrug resistance in enterobacteria to various antibiotics, including carbapenems. Currently, the most suitable approach for the treatment of intestinal infections caused by NDM-producing K. pneumoniae is considered to be the combination of ceftazidime/avibactam with aztreonam. The following case study also illustrates its use in more complicated cases.
Source: Anti-Infectives 3. 3. 2023

News How Do Sleep and Depression Influence Each Other?

It is known that most patients with depression encounter some form of sleep disorder. In the following text, we briefly explore the complex relationship between depression and sleep and offer some practical recommendations that can help patients improve their sleep.
Source: Depression and Anxiety 27. 10. 2021

Journal articles Fracture Liaison Service: pilot project in FH Královské Vinohrady

Author of the article: Kučerová Tereza, Suchoťko Vasyl, Malá Julia, Sotorník Richard, Švec Jan, Kirchhofová Kateřina, Skála-Rosenbaum Jiří, Brunerová Ludmila Source: Clinical Osteology | 1-2/2023 26. 4. 2023

News Effectiveness of Bisoprolol in Patients with Cardiac Arrhythmias – A Systematic Review of Studies

Last year, a Franco-Romanian team published a study that conducted a systematic review of existing evidence on bisoprolol in the context of arrhythmia treatment. The authors noted that bisoprolol, like other beta-blockers (BB), is used for a variety of cardiovascular diseases, but it is not mentioned in the European Society of Cardiology (ESC) guidelines for managing patients with ventricular arrhythmias and preventing sudden cardiac death.
Source: Cardiovascular Continuum 12. 7. 2023

Journal articles Variability of osteogenesis imperfecta manifestations depending on gender: case report

Author of the article: Štěpán Jakub, Kužma Martin, Killinger Zdenko, Payer Juraj Source: Clinical Osteology | 1/2019 26. 8. 2019

Journal articles Risk faktors for development of knee and hip joint osteoarthritis for patients with total endoprosthesis indicated

Author of the article: M. Holubová, M. Čapková, L. Jirásková, K. Šoukalová Source: Česká revmatologie | 1/2019 25. 6. 2019

News Long-Term Effect of Nuclear Magnetic Resonance Therapy on Osteoarthritis – An Unconventional Case Report

Osteoarthritis is among the most common health issues in adults, with its prevalence increasing with advancing age. There is currently no causal therapy for the disease; hence, the standard approach is symptomatic treatment with surgical joint reconstruction in advanced stages of the disease. The presented case report describes a successful case of long-term therapy for osteoarthritis using molecular biophysical stimulation.
Source: Treatment of the Musculoskeletal System 21. 2. 2020

News How to Save a Leg from Amputation?

Feared complications in diabetics include defects in typical locations on the lower limbs. Their presence and frequent recurrences increase the risk of possible amputation of varying degrees, mainly depending on the involvement of deep structures, i.e., tendons, joint capsules, joints, and bones. How can this scenario be avoided? One answer might be HydroTherapy.
Source: Wound Healing 10. 8. 2022

News Pregabalin can be chosen as the 1st line treatment for postherpetic neuralgia

The efficacy of pregabalin in patients with postherpetic neuralgia has been demonstrated in 4 multicenter randomized double-blind placebo-controlled studies.
Source: Neuropathic Pain 22. 6. 2020

News How and when does the reaction to gluten begin in coeliac disease? A new Canadian study offers potential answers

As is well known, coeliac disease is a systemic autoimmune disorder characterised by damage to intestinal epithelial cells (IEC). Canadian researchers have sought to uncover the relationship between intestinal epithelial cells and T lymphocyte activation in this disease. The results of their work provide hope for the potential development of an effective therapy.
Source: 6. 11. 2024

Journal articles Lung cancer prevention and prevention programs

Author of the article: Lubomír Tulinský Source: Časopis lékařů českých | 4/2023 19. 9. 2023

News The Potential of Vinpocetine in the Treatment of Cardiovascular Diseases

Vinpocetine is a nootropic indicated for the symptomatic treatment of cerebral ischemic hypoperfusion, vascular dementia, and reducing the psychological and neurological consequences of cerebral blood supply disorders. Due to its excellent safety profile, tolerance, and complex mechanism of action, it is currently being studied in experimental models of various disorders such as obesity and cardiovascular (CV) diseases including atherosclerosis, neointimal hyperplasia, vasoconstriction, pathological heart remodeling, and ischemic stroke (iCMP). We present an overview of the research findings on vinpocetine in CV diseases.
Source: Pain Management 29. 5. 2024

News Interstitial Lung Processes and Their Fibrotic Progression

Interstitial lung processes (ILPs) include more than 200 clinical units that share diffuse involvement of lung tissue and thus have similar clinical, radiological, and functional findings. However, their broad differential diagnosis is particularly problematic.
Source: Progressive Interstitial Pulmonary Processes 10. 9. 2021

1 64 65 66 67 68 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#